1. ACOG Committee Opinion No. 757: screening for perinatal depression. Obstet Gynecol. 2018;132(5):e208–12.
2. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Interventions to prevent perinatal depression: US preventive services task force recommendation statement. JAMA. 2019;321(6):580–7.
3. Tuten M, Fitzsimons H, Hochheimer M, Jones HE, Chisolm MS. The impact of early substance use disorder treatment response on treatment outcomes among pregnant women with primary opioid use. J Addict Med. 2018;12(4):300–7.
4. American Society of Addiction Medicine. Substance use, misuse, and use disorders during and following pregnancy, with an emphasis on opioids. 2017. https://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2017/01/19/substance-use-misuse-and-use-disorders-during-and-following-pregnancy-with-an-emphasis-on-opioids.
5. Substance Abuse and Mental Health Services Administration. General principles for the use of pharmacological agents to treat individuals with co-occuring mental and substance use disorders. HHS Publication No. SMA12-4689. Substance Abuse and Mental Health Services Administration: Rockville; 2012.